These biomarkers can cause synaptic dysfunction, potentially leading to AD, and inflammatory biomarkers like IL-6, galectin-3 (Gal-3), and IL-1 have been showing a linkage between AD and Covid-19 (Ciaccio et al., 2021). Here, IL1B is linked to Alzheimer disease.